Qube Research & Technologies LTD Greenwich Life Sciences, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$8.31 - $20.32 $21,630 - $52,892
2,603 Added 17.69%
17,317 $345,000
Q4 2023

Feb 13, 2024
BUY
$7.77 - $12.3 $104,149 - $164,869
13,404 Added 1023.21%
14,714 $154,000
Q3 2023

Nov 13, 2023
BUY
$8.41 - $10.66 $11,017 - $13,964
1,310 New
1,310 $11,000

Others Institutions Holding GLSI

# of Institutions
38
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About Greenwich LifeSciences, Inc.

GLSI Quotes by TradingView
  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $158M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email